Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,801-1,825 of 2,022
CompletedNCT04521868

A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
CompletedNCT04922593

Relative Bioavailability of LY03010 Compared to Listed Drug

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
CompletedNCT04689867

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Michigan
Condition
Schizophrenia
CompletedNCT02131129

rTMS in First Episode Psychosis

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
CompletedNCT03745820

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Germany, Japan, Spain, United Kingdom, United States
Sponsor
Biogen
Condition
Schizophrenia
CompletedNCT04251195

Verbal Memory Training Using Virtual Reality in Schizophrenia

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 20 Years to 60 Years
Countries
Canada
Sponsor
The Royal Ottawa Mental Health Centre
Condition
Schizophrenia
CompletedNCT03270098

Improving Cognition Via Exercise in Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Schizophrenia
CompletedNCT05809882

Study of Experience of High-frequency Repetitive Transcranial

This study exists to see whether the medication Experience can play a useful role in care. Researchers are trying to understand whether the medication Experience can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
Rongjun Hospital of Hebei Province Affiliated to North China University of Science and Technology
Condition
Schizophrenia
CompletedNCT05784948

Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis

This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 15 Years to 59 Years
Countries
South Korea
Sponsor
Chonbuk National University Hospital
Condition
Schizophrenia
CompletedNCT04010747

Pilot Study of Motivational Interviewing for Loved Ones

This study exists to see whether the medication Motivational is workable and worth testing more broadly. Researchers are trying to understand what helps the medication Motivational stay useful, realistic, and easier to follow over time.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Boston Medical Center
Condition
Schizophrenia
CompletedNCT05124470

Cognitive Remediation Method by Rhythmic, Vocal and Embodied Musical Learning for Stabilized Schizophrenic Patients

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Toulouse
Condition
Schizophrenia
CompletedNCT02782091

Discriminant Validity of the Multiple Errands Test in Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Schizophrenia
WithdrawnNCT04065360

Group Cognitive Behavioural Family Intervention (CBFI) for People With Schizophrenia and Their Families

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
Hospital Authority, Hong Kong
Condition
Schizophrenia
CompletedNCT05308056

Depth of Anesthesia During Electroconvulsive Therapy

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherOver 18 Years
Countries
Sweden
Sponsor
Region Örebro County
Condition
Schizophrenia
CompletedNCT00635700

Ziprasidone in the Psychosis Prodrome

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 16 Years to 40 Years
Countries
Canada, United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT05601050

Linguistic Predictors of Outcomes in Psychosis

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 40 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
CompletedNCT03370341

Stimulating the Brain to Improve Self-Awareness

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
The University of Texas at Dallas
Condition
Schizophrenia
CompletedNCT05090644

Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on the Isolation of Gene Polymorphism in Schizophrenia in People of the Kazakh Ethnic Group

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Kazakhstan
Sponsor
Asfendiyarov Kazakh National Medical University
Condition
Schizophrenia
TerminatedNCT03588728

tDCS and Cognitive Training Intervention for Chronic Smokers With Schizophrenia

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Schizophrenia
CompletedNCT03503318

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

This study exists to understand how the medication TV-46000 holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication TV-46000 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 13 Years to 65 Years
Countries
Bulgaria, United States
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Schizophrenia
CompletedNCT01602263

Transcranial Direct Current Stimulation (tDCS) and Cognitive Processing

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 79 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Schizophrenia